
Anti-DR4(NT)Antibody
CatalogNo.:1167
Size:100ugIgGinPBS,pH7.4,purifiedbyimmunoaffinitychromatography.
ApoptosisisinducedbycertaincytokinesincludingTNFandFasligandoftheTNFfamilythroughtheirdeathdomain-containingreceptors,TNFR1andFas.AnothercelldeathreceptorwasrecentlyidentifiedanddesignatedDR4(fordeathreceptor4).TheligandforDR4hasbeendesignatedTRAILandisanewmemberoftheTNFfamily.Therefore,DR4isalsocalledTRAILreceptor-1.DR4isexpressedinmosthumantissuesincludingspleen,peripheralblood,smallintestine,andthymus.LikeTNFR1,FasandDR3,DR4mediatesTRAIL-inducedapoptosisandNF-Bactivationinmanytissuesandcells.
Antigen:Peptidecorrespondingtoaa1-20ofhumanDR4matureprotein(accessionno.
ACC51226).
HostSpecies:Rabbit
StABIlizers:None
Preservatives:0.02%sodiumazide.
ThisantibodyrecognizeshumanDR4(57kDa).
APPLICATIONSImmunoblotting:useat2ug/ml.
WesternblotanalysisofDR4inHeLa(H),K562(K),andJurkat(J)wholecelllysatewithDR4antibody
at2ug/ml.
Positivecontrol:WholecelllysatefromHeLa,K562,orJurkatcells.
Thesearerecommendedconcentrations.Endusershoulddetermineoptimalconcentrationfortheirapplications.
DiluteinPBSormediumwhichisidenticaltothatusedintheassaysystem.
Thisantibodyisstableforatleastone(1)yearat-20oC.Avoidmultiplefreeze-thawcycles.
Forinvitroinvestigationaluseonly.Notforuseintherapeuticordiagnosticprocedures.